{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:16:28Z","timestamp":1788142588710,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":74,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Star Macular Disease Foundation","award":["2025-Z-13"],"award-info":[{"award-number":["2025-Z-13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Suprachoroidal injection enables targeted posterior segment drug delivery with reduced anterior segment exposure. Off-label use of the dexamethasone implant (Ozurdex) via the suprachoroidal route may benefit patients with macular edema who have contraindications to intravitreal therapy. This article aims to introduce a two-step surgical technique for suprachoroidal Ozurdex injection and reports its feasibility and short-term outcomes in an illustrative case.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A custom\u2011made injector assembled from a 26\u2011gauge hypodermic needle and an intravenous catheter. The technique involves: (1) injection of 0.3mL sodium hyaluronate viscoelastic into the suprachoroidal space at 4.0\u00a0mm posterior to the limbus; (2) injection of the dexamethasone implant through the same site. The technique was performed in a 37\u2011year\u2011old pregnant woman at 24 weeks of gestation with vitreous hemorrhage and macular edema secondary to proliferative diabetic retinopathy in the left eye immediately following pars plana vitrectomy. Main outcomes included feasibility, safety, best\u2011corrected visual acuity (BCVA), intraocular pressure (IOP) and imaging findings on ultrasound biomicroscopy (UBM) and optical coherence tomography (OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The procedure was completed without intraoperative complications. UBM at postoperative week 1 confirmed Ozurdex within an anechoic suprachoroidal space, which resolved by week 12. BCVA improved from decimal 0.2 (Snellen 4\/20) at baseline to 0.4 (20\/50) at 12 weeks. IOP remained stable (21\u201323 mmHg), with no cataract progression or significant IOP elevation. OCT showed resolution of intraretinal cysts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This two-step technique for suprachoroidal Ozurdex delivery using a custom\u2011made injector with viscoelastic pre\u2011injection is feasible and showed no major safety concerns in this case. It may provide an alternative delivery method for selected patients with non\u2011infectious macular edema who have relative contraindications to intravitreal anti\u2011vascular endothelial growth factor (VEGF) or corticosteroid injections. Further studies are needed to establish safety and efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00883-6","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:07:51Z","timestamp":1781788071000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A two-step approach for suprachoroidal delivery of dexamethasone implant using a custom-made injector"],"prefix":"10.1186","volume":"12","author":[{"given":"Jiyang","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzhong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuou","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaozhu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"issue":"8","key":"883_CR1","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1167\/iovs.12-9872","volume":"53","author":"SR Patel","year":"2012","unstructured":"Patel SR, Berezovsky DE, McCarey BE, Zarnitsyn V, Edelhauser HF, Prausnitz MR. Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci. 2012;53(8):4433\u201341. https:\/\/doi.org\/10.1167\/iovs.12-9872.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"883_CR2","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/aos.14042","volume":"97","author":"Z Habot-Wilner","year":"2019","unstructured":"Habot-Wilner Z, Noronha G, Wykoff CC. Suprachoroidally injected pharmacological agents for the treatment of chorio-retinal diseases: a targeted approach. Acta Ophthalmol. 2019;97(5):460\u201372. https:\/\/doi.org\/10.1111\/aos.14042.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"883_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.oret.2017.07.013","volume":"2","author":"PA Campochiaro","year":"2018","unstructured":"Campochiaro PA, Wykoff CC, Brown DM, Boyer DS, Barakat M, Taraborelli D, et al. Suprachoroidal Triamcinolone Acetonide for Retinal Vein Occlusion: Results of the Tanzanite Study. Ophthalmol Retina. 2018;2(4):320\u20138. https:\/\/doi.org\/10.1016\/j.oret.2017.07.013.","journal-title":"Ophthalmol Retina"},{"issue":"10","key":"883_CR4","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1097\/IAE.0000000000002279","volume":"39","author":"S Yeh","year":"2019","unstructured":"Yeh S, Kurup SK, Wang RC, Foster CS, Noronha G, Nguyen QD, et al. SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS: A Randomized, Phase 2 Study (DOGWOOD). Retina. 2019;39(10):1880\u20138. https:\/\/doi.org\/10.1097\/IAE.0000000000002279.","journal-title":"Retina"},{"issue":"6","key":"883_CR5","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/bjophthalmol-2020-318019","volume":"106","author":"CR Henry","year":"2022","unstructured":"Henry CR, Shah M, Barakat MR, Dayani P, Wang RC, Khurana RN, et al. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA). Br J Ophthalmol. 2022;106(6):802\u20136. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-318019.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"883_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41433-018-0219-8","volume":"33","author":"GG Bastakis","year":"2019","unstructured":"Bastakis GG, Dimopoulos D, Stavrakakis A, Pappas G. Long-term efficacy and duration of action of dexamethasone implant, in vitrectomised and non-vitrectomised eyes with persistent diabetic macular oedema. Eye (Lond). 2019;33(3):411\u20138. https:\/\/doi.org\/10.1038\/s41433-018-0219-8.","journal-title":"Eye (Lond)"},{"issue":"1","key":"883_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40942-024-00625-6","volume":"11","author":"G Pellegrini","year":"2025","unstructured":"Pellegrini G, Bordon AF, Allemann N. Intravitreal dexamethasone implant (Ozurdex(R)) findings over time: ultrasound and ultra-widefield fundus photography. Int J Retina Vitreous. 2025;11(1):7. https:\/\/doi.org\/10.1186\/s40942-024-00625-6.","journal-title":"Int J Retina Vitreous"},{"issue":"10","key":"883_CR8","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.jval.2022.07.008","volume":"25","author":"S Bhattacharyya","year":"2022","unstructured":"Bhattacharyya S, Hariprasad SM, Albini TA, Dutta SK, John D, Padula WV, et al. Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis. Value Health. 2022;25(10):1705\u201316. https:\/\/doi.org\/10.1016\/j.jval.2022.07.008.","journal-title":"Value Health"},{"issue":"1","key":"883_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/11206721251379936","volume":"36","author":"D Zhang","year":"2026","unstructured":"Zhang D, Zhu Q, Huang R, Zhuang A, Zhu D. An ingenious suprachoroidal injector based on the resistance feedback theory for treatment of macular edema: A short-term pilot study. Eur J Ophthalmol. 2026;36(1):174\u201380. https:\/\/doi.org\/10.1177\/11206721251379936.","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"883_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40942-024-00550-8","volume":"10","author":"A Marashi","year":"2024","unstructured":"Marashi A, Baba M, Abu Ghedda S, Kitaz MN, Zazo A. A combination of suprachoroidal injection of triamcinolone using a custom-made needle and intravitreal Ziv-aflibercept every eight weeks to manage naive\/denovo central DME: a single-center retrospective case series. Int J Retina Vitreous. 2024;10(1):30. https:\/\/doi.org\/10.1186\/s40942-024-00550-8.","journal-title":"Int J Retina Vitreous"},{"key":"883_CR11","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.2147\/OPTH.S472910","volume":"18","author":"AE Nawar","year":"2024","unstructured":"Nawar AE, Ali AYA, Massoud OM, Alagorie AR. Effectiveness of Suprachoroidal Injection of Triamcinolone Acetonide in Diabetic Macular Edema Following Pars Plana Vitrectomy Using a Modified Custom Microneedle. Clin Ophthalmol. 2024;18:2049\u201360. https:\/\/doi.org\/10.2147\/OPTH.S472910.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"883_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1167\/iovs.16-20679","volume":"58","author":"B Chiang","year":"2017","unstructured":"Chiang B, Wang K, Ethier CR, Prausnitz MR. Clearance Kinetics and Clearance Routes of Molecules From the Suprachoroidal Space After Microneedle Injection. Invest Ophthalmol Vis Sci. 2017;58(1):545\u201354. https:\/\/doi.org\/10.1167\/iovs.16-20679.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"883_CR13","doi-asserted-by":"publisher","first-page":"NP69","DOI":"10.1177\/11206721251337634","volume":"35","author":"P Neves","year":"2025","unstructured":"Neves P. Suprachoroidal injection of a dexamethasone implant in a case of secondary macular oedema. Eur J Ophthalmol. 2025;35(5):NP69\u201372. https:\/\/doi.org\/10.1177\/11206721251337634.","journal-title":"Eur J Ophthalmol"},{"key":"883_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejpb.2019.08.008","volume":"143","author":"E Ramsay","year":"2019","unstructured":"Ramsay E, Hagstrom M, Vellonen KS, Boman S, Toropainen E, Del Amo EM, et al. Role of retinal pigment epithelium permeability in drug transfer between posterior eye segment and systemic blood circulation. Eur J Pharm Biopharm. 2019;143:18\u201323. https:\/\/doi.org\/10.1016\/j.ejpb.2019.08.008.","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"883_CR15","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.ophtha.2017.03.060","volume":"124","author":"JP Ehlers","year":"2017","unstructured":"Ehlers JP, Kim SJ, Yeh S, Thorne JE, Mruthyunjaya P, Schoenberger SD, et al. Therapies for Macular Edema Associated with Branch Retinal Vein Occlusion: A Report by the American Academy of Ophthalmology. Ophthalmology. 2017;124(9):1412\u201323. https:\/\/doi.org\/10.1016\/j.ophtha.2017.03.060.","journal-title":"Ophthalmology"},{"issue":"4","key":"883_CR16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.ophtha.2014.10.013","volume":"122","author":"S Yeh","year":"2015","unstructured":"Yeh S, Kim SJ, Ho AC, Schoenberger SD, Bakri SJ, Ehlers JP, et al. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology. Ophthalmology. 2015;122(4):769\u201378. https:\/\/doi.org\/10.1016\/j.ophtha.2014.10.013.","journal-title":"Ophthalmology"},{"issue":"1","key":"883_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ophtha.2021.07.009","volume":"129","author":"JP Ehlers","year":"2022","unstructured":"Ehlers JP, Yeh S, Maguire MG, Smith JR, Mruthyunjaya P, Jain N, et al. Intravitreal Pharmacotherapies for Diabetic Macular Edema: A Report by the American Academy of Ophthalmology. Ophthalmology. 2022;129(1):88\u201399. https:\/\/doi.org\/10.1016\/j.ophtha.2021.07.009.","journal-title":"Ophthalmology"},{"issue":"9","key":"883_CR18","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ophtha.2024.02.019","volume":"131","author":"JR Smith","year":"2024","unstructured":"Smith JR, Thorne JE, Flaxel CJ, Jain N, Kim SJ, Maguire MG, et al. Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology. Ophthalmology. 2024;131(9):1107\u201320. https:\/\/doi.org\/10.1016\/j.ophtha.2024.02.019.","journal-title":"Ophthalmology"},{"issue":"1","key":"883_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1167\/iovs.10-5285","volume":"52","author":"JE Chang-Lin","year":"2011","unstructured":"Chang-Lin JE, Attar M, Acheampong AA, Robinson MR, Whitcup SM, Kuppermann BD, et al. Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant. Invest Ophthalmol Vis Sci. 2011;52(1):80\u20136. https:\/\/doi.org\/10.1167\/iovs.10-5285.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"883_CR20","doi-asserted-by":"publisher","unstructured":"Chen M, Jiao W, Liu T, Zhao B. Suprachoroidal injection in the treatment of diabetic macular edema: mechanisms, clinical advances, and future perspectives. Front Med. 2026;13\u20132026. https:\/\/doi.org\/10.3389\/fmed.2026.1797383.","DOI":"10.3389\/fmed.2026.1797383"},{"issue":"1","key":"883_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12886-025-04121-9","volume":"25","author":"W Ma","year":"2025","unstructured":"Ma W, Wang Z, Li Z, Rong W, Cui Q, Hu X. Therapeutic effect of suprachoroidal viscoelastic injection combined with 532 laser photocoagulation in treating rhegmatogenous retinal detachment. BMC Ophthalmol. 2025;25(1):322. https:\/\/doi.org\/10.1186\/s12886-025-04121-9.","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"883_CR22","doi-asserted-by":"publisher","first-page":"5730","DOI":"10.1167\/iovs.11-7525","volume":"52","author":"GS Seiler","year":"2011","unstructured":"Seiler GS, Salmon JH, Mantuo R, Feingold S, Dayton PA, Gilger BC. Effect and distribution of contrast medium after injection into the anterior suprachoroidal space in ex vivo eyes. Invest Ophthalmol Vis Sci. 2011;52(8):5730\u20136. https:\/\/doi.org\/10.1167\/iovs.11-7525.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"883_CR23","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1001\/jamaophthalmol.2024.5202","volume":"143","author":"RH Muni","year":"2025","unstructured":"Muni RH, Melo IM, Demian S, Minelli T, Batawi H, Park J, et al. In-Office Suprachoroidal Viscopexy for Acute Rhegmatogenous Retinal Detachment. JAMA Ophthalmol. 2025;143(1):53\u201360. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.5202.","journal-title":"JAMA Ophthalmol"},{"key":"883_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2026.03.044","volume":"288","author":"T Cai","year":"2026","unstructured":"Cai T, Chen L, Lin Y, Chen S, Wang Y, Huang J, et al. Anterior Ocular Wall Thickness Mapping: Anatomical Adequacy of Fixed-Depth Suprachoroidal Injection. Am J Ophthalmol. 2026;288:1\u201311. https:\/\/doi.org\/10.1016\/j.ajo.2026.03.044.","journal-title":"Am J Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00883-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:43:33Z","timestamp":1788140613000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00883-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00883-6","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study and off-label use of Ozurdex were approved by the Ethics Committee of Peking University People\u2019s Hospital and adhered to the tenets of the Declaration of Helsinki. Written informed consent was obtained from the participant prior to her inclusion in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent has been obtained from the participant for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"113"}}